Course Description
A critical time for patients with mental health disorders is the time of transition from hospital to community services. Patients with certain mental health disorders are at high risk for undesirable outcomes and readmission in the 30 day after hospital discharge. Pharmacists can play a critical role in transitions of care and should be involved in medication reconciliation and interventions as a member of the interdisciplinary team. Pharmacist involvement can improve medication safety, decrease readmissions rates and reduce costs. This presentation will evaluate the evidence for mental health transitions of care programs and assess the role of psychiatric pharmacists in hospital discharges.
Learning Objectives
- Evaluate the evidence for mental health transitions of care programs.
- Assess the role of psychiatric pharmacists in transitions of care programs.
- Recommend strategies to address barriers when transitioning from inpatient mental health services to outpatient primary or mental health care.
Target Audience
If you are a pharmacist, nurse practitioner, or other health care professional involved in the comprehensive medication management of individuals living with mental health and/or substance use disorders, we invite you to participate in this online course.
BCPPs desiring an evidence-based focus on an emerging area of practice and contemporary issues in psychiatric pharmacy at the specialist level are the intended audience of this recertification activity. This activity is designed for BCPPs who learn best from didactic presentations, are auditory and visual learners, and/or who learn best from hands-on-learning and dialoguing with specialist faculty and colleagues.
Faculty
View biographical information
Rachel L. Bauer, PharmD, BCPS, BCPP
Salt Lake City George E. Wahlen Veterans Affairs Medical Center
Salt Lake City, UT
Dr. Bauer is a clinical pharmacy specialist at the Salt Lake City George E. Wahlen VA with clinical practice areas on the acute inpatient psychiatric unit and in mental health pharmacy transitions of care. She earned her Doctor of Pharmacy degree from the University of Tennessee Health Science Center College of Pharmacy (UTHSC-CoP) in 2013. She then worked for a year as a community pharmacist in Memphis, TN. After that, she went on to complete her PGY1 residency in Managed Care with UTHSC-CoP and the Tennessee Department of Mental Health and Substance Abuse Services (TDMHSAS) in 2015 followed by her Psychiatric Pharmacy Practice PGY2 residency at University of North Carolina Medical Center in 2016. She then worked for a year as a clinical pharmacy specialist at a local psychiatric hospital in Salt Lake City before landing her dream job in mental health transitions of care.
Dr. Bauer has served on the SLC VA’s Suicide Prevention Oversight Committee (SPOC) for several years and chaired the committee from 2020-2021. In addition, she serves on the Mental Health High Utilizer Workgroup review committee evaluating possible interventions for veterans with frequent acute care encounters.
Dr. Bauer also teaches Introduction to Neurochemistry and Pharmacology at the University of Utah College of Social Work.
Course Requirements
To receive ACPE credit for this session, you must:
- Register for this course.
- Review the full content of the activity and reflect upon its teachings.
- Complete the evaluation at the end of the activity.
- Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.
Continuing Education Credit and Disclosures
Activity Date: 10/13/2023
ACPE Contact Hours: 1.25
ACPE Number: 0284-0000-23-011-H99-P (Application)
Nursing Credit Reminder: Note that ACPE credit is accepted for ANCC Certification Renewal and AANPCB advanced practice provider content. For specific questions related to your organization's acceptance of ACPE continuing education units, please contact your organization directly.
The American Association of Psychiatric Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
View disclaimer and disclosure of off-label use
Off-Label Use: This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA (see faculty information). The opinions expressed in the educational activity do not necessarily represent the views of AAPP and any educational partners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Disclaimer: Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
View fair balance and integrity statement
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.